Clinical trial · Interventional
The Clinical Significance of Sentinel Lymph Node Imaging Combined With Imaging Examination in Pelvic and Peritoneal Lymphadenectomy for Endometrial Carcinoma
NCT03877627CI-TRIAL-00047992unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this prospective cohort study is to explore the clinical significance of sentinel lymph node imaging combined imaging examination evaluation in pelvic and peritoneal lymphadenectomy for endometrial carcinoma management.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Carcinoma | Endometrial Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Lymphadenectomy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Pelvic and Peritoneal Lymphadenectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Negative 1
- description
- Patients in this arm will not undergo Pelvic and Peritoneal Lymphadenectomy.
- type
- EXPERIMENTAL
- label
- Negative 2
- description
- Patients in this arm will undergo Pelvic and Peritoneal Lymphadenectomy.
- interventionNames
- Procedure: Pelvic and Peritoneal Lymphadenectomy
Primary outcomes (4)
- measure
- the number (s) of pelvic and abdominal lymph node metastasis
- timeFrame
- 1 year during the perioperative period
- description
- the specific number of pelvic and abdominal lymph nodes that are invaded by metastatic endometrial carcinoma
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 10 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: 1. Females who are diagnosed with endometrial carcinoma; 2. Patients who are willing to receive primary non-reserved fertility function surgery to treat their disease; 3. Patients who are agreed to participated in this prospective cohort study. Exclusion Criteria: 1. Patients who still have the will to have pregnancy; 2. Patients who have other diseases or heavy injuries that will interfere with the results; 3. Simultaneous participation in another clinical study with investigational medicinal product(s) or researcher thinks the subjects are not suitable for this trial.
References
Publications (0)
Data not yet available
No reference posted for this study.